New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

China Objective This study aimed to investigate the therapeutic potential of monoclonal antibody (mAb) against HBV as a novel treatment approach to chronic hepatitis B (CHB) in mouse models. Methods ...

Department of Biology, Washington University in St. Louis, St Louis, United States Department of Biology, Stanford University, Stanford, United States Rockefeller University, New York, United States ...

In addition to HBsAg, other viral markers such as hepatitis B core-related antigen (HBcrAg) are available, but their potential association with HBV-specific immune responses is not defined yet, which ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in ... HBV surface antigen (HBsAg) or HBV core antibody (anti-HBc). The most common cause ...

ALT: Alanine aminotransferase; Anti-HBc: Hepatitis B core antibody; Anti-HBe ... and detecting the emergence of drug-resistant mutants. HBV genotypes correlate with spontaneous or interferon ...

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...